盈建科(300935.SZ):致力於建築結構設計和BIM相關軟件產品的開發、銷售及技術服務
格隆匯7月26日丨盈建科(300935.SZ)在投資者互動平台表示,公司致力於建築結構設計和BIM相關軟件產品的開發、銷售及技術服務,專業為建築行業和基礎設施領域提供BIM標準化軟件產品及數字化整體解決方案。公司主營業務涵蓋工業軟件的BIM、CAD以及CAE領域,所涉及的技術是先進製造的重要組成部分,是促進建築設計單位、施工生產單位及科研部門提高智能製造及智能建造等技術創新能力和設計水平、加快設計與交付效率、促進行業數字化轉型和高質量發展的關鍵。未來,公司將根據產業發展方向以及自身的經營情況,適時調整產業佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.